Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are already part of a research group called the Mild Stroke Study 3 cohort
- People who have had an MRI scan with contrast dye within the last 12 months
- People whose eyes are clear enough to be examined, as checked by a study investigator
- People whose near vision, when wearing glasses or contact lenses if needed, meets the minimum level required for this trial (confirm with trial site)
Who may not be able to join:
- People who have a condition known to cause fluid leakage in the retina, such as more than mild diabetic eye disease, a blocked vein in the retina, active eye inflammation, the wet form of age-related macular degeneration, or severely high blood pressure affecting the eyes
- People who have previously had treatment for retinal leakage, such as laser therapy to the retina or injections into the eye
- People who have had eye surgery recently
- People who have been found to have a certain type of narrow structure at the front of the eye, as checked by a torch test (confirm with trial site)
- People who are pregnant or have kidney failure
- People with severe dementia
- People who have a known allergy to a dye called fluorescein
- People who have a history of allergic reactions such as hives from food or medication, or a history of asthma
- People with any other serious or severe medical or mental health conditions
- People who are not able to give informed consent to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Retinal vessel leakage by automated segmentation; Retinal vessel leakage by manual grading
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.